<PAGE>

Exhibit 10.27.5

                               STOCK OPTION GRANT



          REGARDING 1,000,000 SHARES OF COMMON STOCK OF EUROTECH, LTD,
                       A District of Columbia corporation

                       IN FAVOR OF VERDI CONSULTANTS, INC,
                           A Rhode Island corporation


                            DATED: FEBRUARY 28, 2002



NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE
EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES ARE BEING ISSUED IN
RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY MAY NOT BE OFFERED OR SOLD
EXCEPT PURSUANT TO AN EFFEECT1VE REGISTRATION STATEMENT UNDER THE SECURITIES ACT
OR PURSUANT TO AN AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS
THEREUNDER AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES OR BLUE SKY LAWS.

                                       1
<PAGE>

Eurotech, Ltd, a District of Columbia corporation, hereby certifies that, for
value received, Verdi Consultants, Inc. or its registered assigns (the
"Holder"), is entitled, subject to the terms set forth below, to purchase from
the Company up to a total of 1,000,000 shares of common stock of the Company,
par value $ .00025 per share (the "Shares"). This Stock Option Grant (the
"Grant") is subject to the following terms and conditions:

1.       EXERCISE PRICE. Each of the Shares to which the Holder is entitled to
         purchase under this Grant may be purchased by the Holder at a price
         (the "Exercise Price") equal to closing price of the shares of the
         common stock of the Company on the American Stock Exchange, as quoted
         in the Wall Street Journal, as of the date of this Grant (as set forth
         in the cover page hereto).

2.       TERM. The right of the Holder to purchase the Shares under this Grant
         shall terminate on February 28, 2012 (the "Expiration Date").

3.       VESTING. Of the 1,000,000 shares of common stock of the Company that
         the Holder is entitled to purchase hereunder, the Holder shall have the
         right to purchase (and such option shall vest) 125,000 of such shares
         immediately upon the date of this Grant. Of the remaining 875,000
         shares of common stock of the Company that the Holder is entitled to
         purchase hereunder, the Holder shall have the right to purchase 375,000
         of such shares immediately upon the filing of all necessary amendments
         to the Articles of Incorporation of the Company following a special
         meeting of the Company's shareholders to authorize an increase in the
         number of authorized shares of Common Stock to at least 130,000,000
         shares (the "Amendment Date"). The right to purchase the remaining
         500,000 shares shall vest in the amount of 1/nth (where "n" equals the
         remaining number of months in the term of the consulting agreement
         entered into between Verdi Consultants, Inc. and the Company dated
         February 28, 2002 (the "Consulting Agreement"), provided that, if the
         Consultant is retained by the Company for any partial month, the number
         of shares which the Consultant may purchase for that month shall be
         multiplied by the ratio of the number of days that the Consultant was
         retained in such month over the total number of days in such month) of
         such remaining unvested 500,000 shares on the first day of every month
         commencing after the Amendment Date. Notwithstanding the foregoing, if
         the Consulting Agreement is terminated by the Company without "cause"
         (as such term is defined in the Consulting Agreement) or by the
         Consultant under Section 4 of the Consulting Agreement, or if Chad A.
         Verdi dies or is unable to perform his duties as for the consultant to
         the Company or as Vice Chairman (as certified by two independent
         physicians), the Holder of this Grant shall have the right to purchase
         (and such option shall vest) all of the 1,000,000 underlying shares of

                                       2
<PAGE>

         common stock to which this Grant relates, but only if the date of such
         termination, death or disability occurs after the Amendment Date. If
         the Consulting Agreement is terminated by the Company with "cause", the
         Holder shall not have the right to purchase any of the 1,000,000
         underlying shares of common stock of the Company, other than those
         which the Holder had a right to purchase prior to the date of
         termination.

4.       REGISTRATION OF GRANT. The Company shall register this Grant, upon
         records to be maintained by the Company for that purpose in the name of
         the record Holder hereof from time to time. The Company may deem and
         treat the registered Holder of this Grant as the absolute owner hereof
         for the purpose of any exercise hereof or any distribution to the
         Holder, and for all other purposes, and the Company shall not be
         affected by notice to the contrary.

5.       REGISTRATION OF TRANSFERS AND EXCHANGES.

                  (a) The Holder may transfer all or a portion of its rights
hereunder to any entity at least a majority of the voting control of which is
owned at all times by Chad A. Verdi. The Company shall register the transfer of
any portion of this Grant in the records of the Company, upon surrender of this
Grant, with the Form of Assignment attached hereto duly completed and signed, to
the transfer agent of the Company or to the Company. Upon any such registration
or transfer, a new grant to purchase the Shares, in substantially the form of
this Grant (the "New Grant"), evidencing the portion of this Grant so
transferred, shall be issued to the transferee and a New Grant evidencing the
remaining portion of this Grant not so transferred, if any, shall be issued to
the transferring Holder. The acceptance of the New Grant by the transferee
thereof shall be deemed the acceptance of such transferee of all of the rights
and obligations of a holder of this Grant.

                  (b) This Grant is exchangeable, upon the surrender hereof by
the Holder to the office of the Company for one or more New Grants, evidencing
in the aggregate the right to purchase the number of Shares that may then be
purchased hereunder. Any such New Grant will be dated the date of such exchange.

6.       DURATION AND EXERCISE OF GRANT.

                  (a) This Grant shall be exercisable by the registered Holder
on any business day before 5:00 P.M., New York City time, at any time and from
time to time on or after the date hereof to and including the Expiration Date.
At 5:00 P.M., New York City time on the Expiration Date, the portion of this
Grant not exercised prior thereto shall be and become void and of no value.
Prior to the Expiration Date, the Company may not call or otherwise redeem this
Grant without the prior written consent of the Holder.

                  (b) Subject to Sections 5(b), 9 and 13, upon surrender of this
Grant, with the Form of Election to Purchase attached hereto duly completed and
signed, to the Company at its address for notice set forth in Section 15 and
upon payment of the Exercise Price multiplied by the number of Shares that the
Holder intends to purchase hereunder, in the manner provided hereunder, all as
specified by the Holder in the Form of Election to Purchase, the Company shall
promptly (but in no event later than 3 business days after the Date of Exercise

                                       3
<PAGE>

(as defined herein)) issue or cause to be issued and cause to be delivered to or
upon the written order of the Holder and in such name or names as the Holder may
designate, a certificate representing the Shares issuable upon such exercise,
free of restrictive legends except in the event that both a registration
statement covering the resale of the Shares and naming the Holder as a selling
stockholder thereunder (a "Registration Statement") is not then effective and
the Shares are not freely transferable without volume restrictions pursuant to
Rule 144(k) promulgated under tile Securities Act of 1933, as amended (the
"Securities Act"). Any person so designated by the Holder to receive Shares
shall be deemed to have become holder of record of such Shares as of the Date of
Exercise of this Grant. A "Date of Exercise" means the date on which the Company
shall have received (i) this Grant (or any New Grant, as applicable), with the
Form of Election to Purchase attached hereto (or attached to such New Grant)
appropriately completed and duly signed, and (ii) payment of the Exercise Price
for the number of Shares so indicated by the holder hereof to be purchased.

7.       PIGGYBACK REGISTRATION RIGHTS. During the term of this Grant, the
         Company may not file any registration statement with the Securities and
         Exchange Commission (other than registration statements of the Company
         filed on Form S-8 or Form S-4, each as promulgated under the Securities
         Act, pursuant to which the Company is registering securities pursuant
         to a Company employee benefit plan or pursuant to a merger, acquisition
         or similar transaction including supplements thereto, but not
         additionally filed registration statements in respect of such
         securities) at any time when there is not an effective Registration
         Statement, unless the Company provides the Holder with not less than 20
         days notice to the Holder notice of its intention to file such
         registration statement and provides the Holder the option to include
         any or all of the applicable Shares therein. The piggyback registration
         rights granted to the Holder pursuant to this Section 7 shall continue
         until all of the Holder's Shares have been sold in accordance with an
         effective registration statement or upon the Expiration Date. The
         Company will pay all registration expenses in connection therewith.

8.       DEMAND REGISTRATION RIGHTS. At any time during the term of this Grant,
         when the Shares are not registered pursuant to an effective
         Registration Statement, the Holder may make a written request for the
         registration under the Securities Act (a "Demand Registration"), of all
         of the Shares (the "Registrable Securities"), and the Company shall use
         its best efforts to effect such Demand Registration as promptly as
         possible, but in any case within 90 days thereafter. Any request for a
         Demand Registration shall specify the aggregate number of Registrable
         Securities proposed to be sold and shall also specify the intended
         method of disposition thereof. The right to cause a registration of the
         Registrable Securities under this Section 8 shall be limited to one
         such registration. In any registration initiated as a Demand
         Registration, the Company will pay all of its registration expenses in
         connection therewith. A Demand Registration shall not be counted as
         Demand Registration hereunder until the registration statement filed
         pursuant to the Demand Registration has been declared effective by the

                                       4
<PAGE>

         Securities and Exchange Commission and maintained continuously
         effective for a period of at least 360 days or such shorter period when
         all Registrable Securities included therein have been sold in
         accordance with such registration statement, provided, however that any
         days on which such registration statement is not effective or on which
         the Holder is not permitted by the Company or any governmental
         authority to sell Shares under such registration statement shall not
         count towards such 360 day period.

9.       PAYMENT OF TAXES. The Company will pay all documentary stamp taxes
         attributable to the issuance of Shares upon the exercise of this Grant;
         provided, however, that the Company shall not be required to pay any
         tax which may be payable in respect of any transfer involved in the
         registration of any certificates for Shares or New Grants in a name
         other than that of the Holder. The Holder shall be responsible for all
         other tax liability that may arise as a result of holding or
         transferring this Grant or receiving Shares upon exercise hereof.

10.      REPLACEMENT OF GRANT. If this Grant is mutilated, lost, stolen or
         destroyed, the Company shall issue or cause to be issued in exchange
         and substitution for and upon cancellation hereof, or in lieu of and
         substitution for this Grant, a New Grant, but only upon receipt of
         evidence reasonably satisfactory to the Company of such loss, theft or
         destruction and indemnity, if requested, satisfactory to it. Applicants
         for a New Grant under such circumstances shall also comply with such
         other reasonable regulations and procedures and pay such other
         reasonable charges as the Company may prescribe.

11.      RESERVATION OF SHARES. The Company covenants that it will at all times
         after the Amendment Date, reserve and keep available out of the
         aggregate of its authorized but unissued shares of common stock of the
         Company, solely for the purpose of enabling it to issue Shares upon
         exercise of this Grant as herein provided, the number of Shares which
         are then issuable and deliverable upon the exercise of this entire
         Grant, free from preemptive rights or any other actual contingent
         purchase rights of persons other than the Holder (taking into account
         the adjustments and restrictions of Section 12). The Company covenants
         that all Shares that shall be so issuable and deliverable shall, upon
         issuance and the payment of the applicable Exercise Price in accordance
         with the terms hereof, are duly and validly authorized, issued and
         fully paid and nonassessable.

12.      CERTAIN ADJUSTMENTS. The number of Shares issuable upon exercise of
         this Grant is subject to adjustment from time to time as set forth in
         this Section 12.

         (a) If the Company, at any time while this Grant is outstanding, (i)
shall pay a stock dividend (except scheduled dividends paid on outstanding
preferred stock as of the date hereof which contain a stated dividend rate) or
otherwise make a distribution or distributions on shares of its common stock or
on any other class of capital stock payable in shares of common stock of the
Company, (ii) subdivide outstanding shares of common stock into a larger number
of shares, or (iii) combine outstanding shares of common stock into a smaller

                                       5
<PAGE>

number of shares, then the number of Shares for which this Grant may be
exercised will be ratably adjusted. Any adjustment made pursuant to this Section
12 shall become effective immediately after the record date for the
determination of stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a
subdivision or combination, and shall apply to successive subdivisions and
combinations.

         (b) In case of any reclassification of the shares of the common stock
of the Company, any consolidation or merger of the Company with or into another
person, the sale or transfer of all or substantially all of the assets of the
Company or any compulsory share exchange pursuant to which the shares of common
stock of the Company is converted into other securities, cash or property, then
the Holder shall have the right thereafter to exercise this Grant only into the
shares of stock and other securities and property receivable upon or deemed to
be held by holders of shares of common stock of the Company following such
reclassification, consolidation, merger, sale, transfer or share exchange, and
the Holder shall be entitled upon such event to receive such amount of
securities or property equal to the amount of Shares such Holder would have been
entitled to had such Holder exercised this Grant immediately prior to such
reclassification, consolidation, merger, sale, transfer or share exchange. The
terms of any such consolidation, merger, sale, transfer or share exchange shall
include such terms so as to continue to give to the Holder the right to receive
the securities or property set forth in this Section 12(b) upon any exercise
following any such reclassification, consolidation, merger, sale, transfer or
share exchange.

         (c) For the purposes of this Section 12, the following clauses shall
also be applicable:

                  (i) RECORD DATE. In case the Company shall take a record of
         the holders of its shares of common stock for the purpose of entitling
         them (a) to receive a dividend or other distribution payable in shares
         of the common stock of the Company or in securities convertible or
         exchangeable into shares of common stock of the Company, or (b) to
         subscribe for or purchase shares of common stock of the Company or
         securities convertible or exchangeable into shares of common stock of
         the Company, then such record date shall be deemed to be the date of
         the issue or sale of the shares of common stock of the Company deemed
         to have been issued or sold upon the declaration of such dividend or
         the making of such other distribution or the date of the granting of
         such right of subscription or purchase, as the case may be.

                  (ii) TREASURY SHARES. The number of shares of common stock of
         the Company outstanding at any given time shall not include shares
         owned or held by or for the account of the Company, and the disposition
         of any such shares shall be considered an issue or sale of shares of
         the common stock of the Company.

                                       6
<PAGE>

         (d) All calculations under this Section 12 shall be made to the nearest
cent or the nearest 1/100th of a share, as the case may be.

         (f)      If:

                  (i) the Company shall declare a dividend (or any other
         distribution) on its shares of common stock; or

                  (ii) the Company shall declare a special non-recurring cash
         dividend on or a redemption of its Common Stock; or

                  (iii) the Company shall authorize the granting to all holders
         of shares of the common stock of the Company rights or warrants to
         subscribe for or purchase any shares of capital stock of any class or
         of any rights; or

                  (iv) the approval of any stockholders of the Company shall be
         required in connection with any reclassification of the shares of
         common stock of the Company, any consolidation or merger to which the
         Company is a party, any sale or transfer of all or substantially all of
         the assets of the Company, or any compulsory share exchange whereby the
         shares of the common stock is converted into other securities, cash or
         property; or

                  (v) the Company shall authorize the voluntary dissolution,
         liquidation or winding up of the affairs of the Company,

then the Company shall cause to be mailed to each Holder at their last addresses
as they shall appear upon the records of the Company, at least 30 calendar days
prior to the applicable record or effective date hereinafter specified, a notice
stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to
be taken, the date as of which the holders of shares of the common stock of the
Company of record to be entitled to such dividend, distributions, redemption,
rights or warrants are to be determined or (y) the date on which such
reclassification, consolidation, merger, sale, transfer or share exchange is
expected to become effective or close, and the date as of which it is expected
that holders of shares of the common stock of the Company of record shall be
entitled to exchange their shares of common stock of the Company for securities,
cash or other property deliverable upon such reclassification, consolidation,
merger, sale, transfer, share exchange, dissolution, liquidation or winding up;
PROVIDED, HOWEVER, that the failure to mail such notice or any defect therein or
in the mailing thereof shall not affect the validity of the corporate action
required to be specified in such notice.

13.      PAYMENT OF EXERCISE PRICE. The Holder may pay the Exercise Price in one
         of the following manners:

         (a)      CASH EXERCISE. The Holder shall deliver immediately available
                  funds; or

                                       7
<PAGE>

         (b)      CASHLESS EXERCISE. The Holder shall surrender this Grant to
                  the Company together with a notice of cashless exercise, in
                  which event the Company shall issue to the Holder the number
                  of Shares determined as follows:

                  X= Y - [(Y*A)/B], where:

                  X= the actual number of Shares to be issued to the Holder.

                  Y= the number of Shares with respect to which this Grant is
                  being exercised.

                  A= the Exercise Price.

                  B= the closing sale price of shares of the common stock of the
                  Company on the American Stock Exchange on the Date of
                  Exercise, as reported in the Wall Street Journal.

For purposes of Rule 144 promulgated under the Securities Act, it is intended,
understood and acknowledged that the Shares issued in a cashless exercise
transaction shall be deemed to have been acquired by the Holder, and the holding
period for the Shares shall be deemed to have been commenced, on the issue date.

14.      FRACTIONAL SHARES. The Company shall not be required to issue or cause
         to be issued fractional Shares on the exercise of this Grant. The
         number of full Shares that shall be issuable upon the exercise of this
         Grant shall be computed on the basis of the aggregate number of Shares
         purchasable on exercise of this Grant so presented. If any fraction of
         a Share would, except for the provisions of this Section 11, be
         issuable on the exercise of this Grant, the Company shall pay an amount
         in cash equal to the Exercise Price multiplied by such fraction.

15.      REPLACEMENT OPTION GRANT. At any time prior to the Expiration Date,
         upon the written request of the Consultant, the Company shall deliver
         to the Consultant a replacement Stock Option Grant containing the
         identical terms hereof, except that such replacement Stock Option Grant
         shall set forth the portion of the Grant that then remains unexercised.

16.      NOTICES. Any and all notices or other communications or deliveries
         hereunder shall be in writing and shall be deemed given and effective
         on the earliest of (i) the date of transmission, if such notice or
         communication is delivered via facsimile at the facsimile telephone
         number specified in this Section 15 prior to 7:00 p.m. (New York City
         time) on a business day, (ii) the business day after the date of
         transmission, if such notice or communication is delivered via
         facsimile at the facsimile telephone number specified in this Section
         later than 7:00 p.m (New York City time) on any date and earlier than
         11:59 p.m. (New York City time) on such date, (iii) the business day
         following the date of mailing, if sent by nationally recognized
         overnight courier service, or (iv) upon actual receipt by the party to

                                       8
<PAGE>

         whom such notice is required to be given. The addresses for such
         communications shall be: (i) if to the Company, to 10306 Eaton Place,
         Suite 220, Fairfax, Virginia 22030, Attention: Chief Financial Officer
         or (ii) if to the Holder, to the Holder at the address or facsimile
         number appearing on the records of the Company or such other address or
         facsimile number as the Holder may provide to the Company in accordance
         with this Section 15.

17.      TRANSFER AGENT. The Company shall serve as transfer agent under this
         Grant. Upon 30 days' notice to the Holder, the Company may appoint a
         new transfer agent. Any corporation into which the Company or any new
         transfer agent may be merged or any corporation resulting from any
         consolidation to which the Company or any new transfer agent shall be a
         party or any corporation to which the Company or any new transfer agent
         transfers substantially all of its corporate trust or shareholders
         services business shall be a successor transfer agent under this Grant
         without any further act. Any such new transfer agent shall promptly
         cause notice of its succession as transfer agent to be mailed (by first
         class mail, postage prepaid) to the Holder at the Holder's last address
         as shown on the records of the Company.

18.      MISCELLANEOUS.

                    (a) This Grant shall be binding on and inure to the benefit
of the parties hereto and their respective successors and assigns. This Grant
may be amended only in writing signed by the Company and the Holder and their
successors and assigns,

                    (b) Subject to Section 17(a), above, nothing in this Grant
shall be construed to give to any person or corporation other than the Company
and the Holder any legal or equitable right, remedy or cause under this Grant.
This Grant shall inure to the sole and exclusive benefit of the Company and the
Holder.

                    (c) This Grant shall be governed by and construed and
enforced in accordance with the internal laws of the State of New York without
regard to the principles of conflicts of law thereof.

                    (d) Any and all disputes arising out of this Grant will be
determined by submission to binding arbitration before a three-member arbitral
panel, which arbitration shall be conducted in New York, New York, or
Providence, Rhode Island, pursuant to the Rules of Arbitration of the American
Arbitration Association, the jurisdiction to which all parties hereto, as well
as their successors, assigns and transferees, hereby consent. The Company shall
pay all costs and fees relating to such arbitration, including the reasonable
attorneys fees and costs of the Consultant, including the deposit of a
reasonable retainer to the Consultant's legal counsel, which attorney fees shall
be paid by the Company when they are incurred, unless an award is made in favor
of the Company, in which case the Consultant shall immediately reimburse the
Company for all costs and fees paid by the Company on the Consultant's behalf,
including, without limitation, the attorneys fees and costs of the Consultant,
one-half of the cost of commencing the arbitration, and one-half of the costs
and fees of the three-member arbitral panel.

                                       9
<PAGE>

                    (e) The headings herein are for convenience only, do not
constitute a part of this Grant and shall not be deemed to limit or affect any
of the provisions hereof.

                    (f) In case any one or more of the provisions of this Grant
shall be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Grant shall not in
anyway be affected or impaired thereby and the parties will attempt in good
faith to agree upon a valid and enforceable provision which shall be a
commercially reasonable substitute therefore, and upon so agreeing, shall
incorporate such substitute provision in this Grant.

              IN WITNESS WIHEREOF, the Company has caused this Grant to be duly
executed by its authorized officer as of the date first indicated above.

                                    EUROTECH, LTD.

                                    By:  /S/ DON V. HAHNFELDT
                                         --------------------
                                    Name:   Don V. Hahnfeldt
                                    Title: President and Chief Executive Officer

                                    AND

                                    /S/ RANDOLPH A. GRAVES, JR.
                                    ---------------------------
                                    Name: Randolph A. Graves, Jr.
                                    Title:  Corporate Secretary

                                       10
<PAGE>

                          FORM OF ELECTION TO PURCHASE

(To be executed by the Holder to exercise the right to purchase shares of common
stock of the Company under the foregoing Grant)

To Eurotech, Ltd.:

         In accordance with the Grant enclosed with this Form of Election to
Purchase, the undersigned hereby irrevocably elects to
purchase__________________ shares of common stock, par value $00025 per share,
of Eurotech, Ltd. (the "Common Stock") and, if such Holder is not utilizing the
cashless exercise provisions set forth in this Grant, encloses herewith
$_______________ in cash, certified or official bank check or checks, which sum
represents the aggregate Exercise Price (as defined in the Grant) for the number
of shares of Common Stock to which this Form of Election to Purchase relates,
together with any applicable taxes payable by the undersigned pursuant to the
Grant.

         The undersigned requests that certificates for the shares of Common
Stock issuable upon this exercise be issued in the name of

                                                PLEASE INSERT SOCIAL SECURITY OR
                                                       TAX IDENTIFICATION NUMBER

                                                --------------------------------

                         (Please print name and address)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

         If the number of shares of Common Stock issuable upon this exercise
shall not be all of the shares of Common Stock which the undersigned is entitled
to purchase in accordance with the enclosed Grant, the undersigned requests that
a New Grant (as defined in (the Grant) evidencing the right to purchase the
shares of Common Stock not issuable pursuant to the exercise evidenced hereby be
issued in the name of and delivered to:

                         (Please print name and address)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Dated: ___________                  Name of Holder:

                                    (Print)_________________________

                                    (By:) __________________________
                                    (Name:)
                                    (Title:)

                                    (Signature must conform in all respects to
                                    name of holder as specified on the face of
                                    the Grant)

                                       11
<PAGE>

                               FORM OF ASSIGNMENT

            [To be completed and signed only upon transfer of Grant]

          FOR VALUE RECEIVED, the undersigned hereby sells, assigns and
transfers unto __________________________________ the right represented by the
within Grant to purchase __________________ shares of Common Stock of Eurotech,
Ltd. to which the within Grant relates and appoints ___________________ attorney
to transfer said right on the books of Eurotech, Ltd. with full power of
substitution in the premises.

Dated:

-------------------, -------

                     -----------------------------------------------------------
                    (Signature must conform in all respects to name of holder as
                                             specified on the face of the Grant)


                                            -------------------------
                                            Address of Transferee

                                            --------------------------

                                            --------------------------


In the Presence of:


--------------------------

                                       12